ARCH.V - Arch Biopartners Inc.

TSXV - TSXV Real Time Price. Currency in CAD
Currency in CAD

Valuation Measures4

Market Cap (intraday) 134.78M
Enterprise Value 139.01M
Trailing P/E 232.14
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)51.67
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -128.71

Trading Information

Stock Price History

Beta (5Y Monthly) 1.11
52-Week Change 3-34.03%
S&P500 52-Week Change 31.77%
52 Week High 33.8500
52 Week Low 31.8500
50-Day Moving Average 32.0873
200-Day Moving Average 32.6940

Share Statistics

Avg Vol (3 month) 335.99k
Avg Vol (10 day) 323.89k
Shares Outstanding 562.4M
Implied Shares Outstanding 6N/A
Float 848.61M
% Held by Insiders 119.15%
% Held by Institutions 10.00%
Shares Short (May 14, 2023) 421.3k
Short Ratio (May 14, 2023) 40.59
Short % of Float (May 14, 2023) 4N/A
Short % of Shares Outstanding (May 14, 2023) 40.03%
Shares Short (prior month Apr 13, 2023) 4225.65k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sept 12, 2000
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sept 29, 2022
Most Recent Quarter (mrq)Dec 30, 2022


Profit Margin 0.00%
Operating Margin (ttm)-314.91%

Management Effectiveness

Return on Assets (ttm)-170.05%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)964.5k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-0.00%
Gross Profit (ttm)-502.88k
Net Income Avi to Common (ttm)-3.39M
Diluted EPS (ttm)-0.0600
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)159.82k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.39M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.25
Book Value Per Share (mrq)-0.07

Cash Flow Statement

Operating Cash Flow (ttm)-856.07k
Levered Free Cash Flow (ttm)-250.01k